Cui, A. et al. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29–30, 100587 (2020).
Google Scholar
Murphy, L. et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 59, 1207–1213 (2008).
Google Scholar
Jin, X. et al. Economic and humanistic burden of osteoarthritis: an updated systematic review of large sample studies. Pharmacoeconomics 41, 1453–1467 (2023).
Google Scholar
Long, H. et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol. 74, 1172–1183 (2022).
Google Scholar
Prieto-Alhambra, D. et al. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann. Rheum. Dis. 73, 1659–1664 (2014).
Google Scholar
Altman, R. et al. Development of criteria for the classification and reporting of osteoarthritis. classification of osteoarthritis of the knee. diagnostic and therapeutic criteria committee of the American Rheumatism Association. Arthritis Rheum. 29, 1039–1049 (1986).
Google Scholar
Zhang, W. et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann. Rheum. Dis. 69, 483–489 (2010).
Google Scholar
Wang, Q. et al. Evaluation of the diagnostic performance of American College of Rheumatology, EULAR, and national institute for health and clinical excellence criteria against clinically relevant knee osteoarthritis: data from the CHECK cohort. Arthritis Care Res. 76, 511–516 (2024).
Google Scholar
Wang, Q. et al. Diagnosis for early stage knee osteoarthritis: probability stratification, internal and external validation; data from the CHECK and OAI cohorts. Semin. Arthritis Rheum. 55, 152007 (2022).
Google Scholar
Mahmoudian, A., Lohmander, L. S., Mobasheri, A., Englund, M. & Luyten, F. P. Early-stage symptomatic osteoarthritis of the knee — time for action. Nat. Rev. Rheumatol. 17, 621–632 (2021).
Google Scholar
Arden, N. K. et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat. Rev. Rheumatol. 17, 59–66 (2021).
Google Scholar
Bannuru, R. R. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27, 1578–1589 (2019).
Google Scholar
Bruyère, O. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Semin. Arthritis Rheum. 49, 337–350 (2019).
Google Scholar
Veronese, N. et al. Multimodal multidisciplinary management of patients with moderate to severe pain in knee osteoarthritis: a need to meet patient expectations. Drugs 82, 1347–1355 (2022).
Google Scholar
European Medicines Agency. Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. EMA (2010).
US Food and Drug Administration. Osteoarthritis: structural endpoints for the development of drugs, devices, and biological products for treatment — guidance for industry. fda.gov (2018).
Kim, J. S. et al. FDA/arthritis foundation osteoarthritis drug development workshop recap: assessment of long-term benefit. Semin. Arthritis Rheum. 56, 152070 (2022).
Google Scholar
Englund, M. & Turkiewicz, A. Pain in clinical trials for knee osteoarthritis: estimation of regression to the mean. Lancet Rheumatol. 5, e309–e311 (2023).
Google Scholar
Berenbaum, F. et al. General safety and tolerability of subcutaneous tanezumab for osteoarthritis: a pooled analysis of three randomized, placebo-controlled trials. Arthritis Care Res. 74, 918–928 (2022).
Google Scholar
Hiligsmann, M. et al. Patients’ preferences for osteoarthritis treatment: the value of stated-preference studies. Aging Clin. Exp. Res. 31, 1–3 (2019).
Google Scholar
The Professional Society for Health Economics and Outcomes Research. Patient-Centered Special Interest Group. (2025).
Ackerman, I. N. et al. Preferences for disease-related education and support among younger people with hip or knee osteoarthritis. Arthritis Care Res. 69, 499–508 (2017).
Google Scholar
Bunzli, S. et al. Misconceptions and the acceptance of evidence-based nonsurgical interventions for knee osteoarthritis. a qualitative study. Clin. Orthop. Relat. Res. 477, 1975–1983 (2019).
Google Scholar
Botto-van Bemden, A., Adebajo, A. O. & Fitzpatrick, C. M. Patient and public involvement in rheumatic and musculoskeletal research: an idea whose time has firmly come. BMC Rheumatol. 7, 12 (2023).
Google Scholar
Felson, D. T. & Zhang, Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 41, 1343–1355 (1998).
Google Scholar
Parsons, C. et al. How well do radiographic, clinical and self-reported diagnoses of knee osteoarthritis agree? Findings from the Hertfordshire cohort study. Springerplus 4, 177 (2015).
Google Scholar
Parsons, C. et al. Concordance between clinical and radiographic evaluations of knee osteoarthritis. Aging Clin. Exp. Res. 30, 17–25 (2018).
Google Scholar
Neogi, T. et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 339, b2844 (2009).
Google Scholar
Smith, S. L. & Walsh, D. A. Osteoarthritis pain phenotypes: how best to cut the cake? Osteoarthritis Cartilage 32, 124–127 (2024).
Google Scholar
Zhang, D., Deveza, L. A., Tan, B. Y., Dear, B. & Hunter, D. J. Antidepressants to manage osteoarthritic pain: the value of pain phenotyping. Drugs Aging 42, 183–193 (2025).
Google Scholar
Knights, A. J., Redding, S. J. & Maerz, T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr. Opin. Rheumatol. 35, 128–134 (2023).
Google Scholar
Pegreffi, F., et al. Prevalence of sarcopenia in knee osteoarthritis: a systematic review and meta-analysis. J. Clin. Med. 12, 1532 (2023).
Google Scholar
Moradi, K. et al. Erosive hand osteoarthritis and sarcopenia: data from Osteoarthritis Initiative cohort. Ann. Rheum. Dis. 83, 799–806 (2024).
Google Scholar
Jin, Z., Wang, R., Jin, L., Wan, L. & Li, Y. Causal relationship between sarcopenia with osteoarthritis and the mediating role of obesity: a univariate, multivariate, two-step mendelian randomization study. BMC Geriatr. 24, 469 (2024).
Google Scholar
Pineda-Moncusí, M. et al. Classification of patients with osteoarthritis through clusters of comorbidities using 633330 individuals from Spain. Rheumatology 62, 3592–3600 (2023).
Google Scholar
Ramazanian, T., Fu, S., Sohn, S., Taunton, M. J. & Kremers, H. M. Prediction models for knee osteoarthritis: review of current models and future directions. Arch. Bone Jt Surg. 11, 1–11 (2023).
Google Scholar
Barnes, P. J. Endo-phenotyping of COPD patients. Expert. Rev. Respir. Med. 15, 27–37 (2021).
Google Scholar
Foppiano, F. & Schaub, B. Childhood asthma phenotypes and endotypes: a glance into the mosaic. Mol. Cell Pediatr. 10, 9 (2023).
Google Scholar
Deveza, L. A., Nelson, A. E. & Loeser, R. F. Phenotypes of osteoarthritis: current state and future implications. Clin. Exp. Rheumatol. 37, 64–72 (2019).
Google Scholar
Mobasheri, A. & Loeser, R. Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development. Nat. Rev. Rheumatol. 20, 525–526 (2024).
Google Scholar
Van Spil, W. E., Kubassova, O., Boesen, M., Bay-Jensen, A. C. & Mobasheri, A. Osteoarthritis phenotypes and novel therapeutic targets. Biochem. Pharmacol. 165, 41–48 (2019).
Google Scholar
Ehrlich, G. E. Osteoarthritis beginning with inflammation. Definitions and correlations. JAMA 232, 157–159 (1975).
Google Scholar
Berenbaum, F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 21, 16–21 (2013).
Google Scholar
Mobasheri, A. et al. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Curr. Opin. Rheumatol. 31, 80–89 (2019).
Google Scholar
Robinson, W. H. et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 580–592 (2016).
Google Scholar
van Helvoort, E. M. et al. Cohort profile: the applied public-private research enabling osteoarthritis clinical headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers. BMJ Open 10, e035101 (2020).
Google Scholar
Schieker, M. et al. Effects of interleukin-1β inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 173, 509–515 (2020).
Google Scholar
Mobasheri, A. et al. Recent advances in understanding the phenotypes of osteoarthritis. F1000Res. 8, F1000 (2019).
Google Scholar
Collins, J. E., Neogi, T. & Losina, E. Trajectories of structural disease progression in knee osteoarthritis. Arthritis Care Res. 73, 1354–1362 (2021).
Google Scholar
Roemer, F. W. et al. Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? Radiology 274, 810–820 (2015).
Google Scholar
Karsdal, M. A. et al. OA phenotypes, rather than disease stage, drive structural progression — identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA. Osteoarthritis Cartilage 23, 550–558 (2015).
Google Scholar
Collins, J. E. et al. Semiquantitative imaging biomarkers of knee osteoarthritis progression: data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Arthritis Rheumatol. 68, 2422–2431 (2016).
Google Scholar
Bacon, K., LaValley, M. P., Jafarzadeh, S. R. & Felson, D. Does cartilage loss cause pain in osteoarthritis and if so, how much? Ann. Rheum. Dis. 79, 1105–1110 (2020).
Google Scholar
Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis — results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13, 361–367 (2005).
Google Scholar
Roemer, F. W. et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann. Rheum. Dis. 70, 1804–1809 (2011).
Google Scholar
Ramezanpour, S. et al. Impact of sustained synovitis on knee joint structural degeneration: 4-Year MRI data from the osteoarthritis initiative. J. Magn. Reson. Imaging 57, 153–164 (2023).
Google Scholar
Conaghan, P. G. et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann. Rheum. Dis. 69, 644–647 (2010).
Google Scholar
Felson, D. T. et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann. Intern. Med. 139, 330–336 (2003).
Google Scholar
Yusuf, E., Kortekaas, M. C., Watt, I., Huizinga, T. W. & Kloppenburg, M. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Ann. Rheum. Dis. 70, 60–67 (2011).
Google Scholar
Roemer, F. W., Collins, J. E., Neogi, T., Crema, M. D. & Guermazi, A. Association of knee OA structural phenotypes to risk for progression: a secondary analysis from the foundation for national institutes of health osteoarthritis biomarkers study (FNIH). Osteoarthritis Cartilage 28, 1220–1228 (2020).
Google Scholar
Roemer, F. W. et al. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann. Rheum. Dis. 68, 1461–1465 (2009).
Google Scholar
Hunter, D. J. et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum. 54, 1529–1535 (2006).
Google Scholar
McCague, C. et al. Introduction to radiomics for a clinical audience. Clin. Radiol. 78, 83–98 (2023).
Google Scholar
Li, S. et al. Integrating radiomics and neural networks for knee osteoarthritis incidence prediction. Arthritis Rheumatol. 76, 1377–1386 (2024).
Google Scholar
Gao, S. et al. Cartilage T2 mapping-based radiomics in knee osteoarthritis research: Status, progress and future outlook. Eur. J. Radiol. 181, 111826 (2024).
Google Scholar
Bowes, M. A. et al. Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative. Ann. Rheum. Dis. 80, 502–508 (2021).
Google Scholar
Rousseau, J. C., Chapurlat, R. & Garnero, P. Soluble biological markers in osteoarthritis. Ther. Adv. Musculoskelet. Dis. 13, 1759720×211040300 (2021).
Google Scholar
Kjelgaard-Petersen, C. et al. Establishment of a human synovium and cartilage co-culture. Osteoarthritis Cartilage 25, S276–S277 (2017).
Google Scholar
Kraus, V. B. et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium. Ann. Rheum. Dis. 76, 186–195 (2017).
Google Scholar
Hosmer, D. W. Jr., Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression (Wiley, 2013).
Garnero, P., Sornay-Rendu, E. & Chapurlat, R. The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort. Osteoarthritis Cartilage 28, 468–474 (2020).
Google Scholar
Garnero, P., Gineyts, E., Rousseau, J. C., Sornay-Rendu, E. & Chapurlat, R. D. Plasma cartilage acidic protein 1 measured by ELISA is associated with the progression to total joint replacement in postmenopausal women. J. Rheumatol. 51, 176–180 (2024).
Google Scholar
Rousseau, J. C., Sornay-Rendu, E., Bertholon, C., Garnero, P. & Chapurlat, R. Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study. Osteoarthritis Cartilage 23, 1736–1742 (2015).
Google Scholar
Rousseau, J. C. et al. Association of circulating microRNAs with prevalent and incident knee osteoarthritis in women: the OFELY study. Arthritis Res. Ther. 22, 2 (2020).
Google Scholar
Yu, S. P. et al. Association of biochemical markers with bone marrow lesion changes on imaging-data from the foundation for the national institutes of health osteoarthritis biomarkers consortium. Arthritis Res. Ther. 26, 30 (2024).
Google Scholar
Kraus, V. B., Catterall, J., Soderblom, E., Moseley, M. A. & Suchindran, S. Development of a serum biomarker panel highly predictive of a knee osteoarthritis diagnosis. Osteoarthritis Cartilage 24, S72 (2016).
Google Scholar
Zhou, K. et al. A “best-in-class” systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. Sci. Adv. 9, eabq5095 (2023).
Google Scholar
Kraus, V. B. et al. An osteoarthritis pathophysiological continuum revealed by molecular biomarkers. Sci. Adv. 10, eadj6814 (2024).
Google Scholar
Council Conclusions on Personalised Medicine for Patients. European Commission. (2015).
Harrison, R. G. The outgrowth of the nerve fiber as a mode of protoplasmic movement. J. Exp. Zool. 9, 787–846 (1910).
Google Scholar
Lee, D., Erickson, A., Dudley, A. T. & Ryu, S. A microfluidic platform for stimulating chondrocytes with dynamic compression. J. Vis. Exp. (2019).
Google Scholar
Liu, H. et al. Cartilage-on-a-chip with magneto-mechanical transformation for osteoarthritis recruitment. Bioact. Mater. 33, 61–68 (2024).
Google Scholar
Rosser, J. et al. Microfluidic nutrient gradient-based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model. Mater. Today Bio. 4, 100023 (2019).
Google Scholar
Pasztorek, M., et al. Exploring osteoarthritis dynamics: patient-specific cartilage samples in an organ-on-a-chip model. Cartilage (2024).
Google Scholar
McCabe, C., Claxton, K. & Culyer, A. J. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 26, 733–744 (2008).
Google Scholar
Losina, E. et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch. Intern. Med. 169, 1113–1121 (2009). discussion 21–2.
Google Scholar
Mari, K., Dégieux, P., Mistretta, F., Guillemin, F. & Richette, P. Cost utility modeling of early vs late total knee replacement in osteoarthritis patients. Osteoarthritis Cartilage 24, 2069–2076 (2016).
Google Scholar
Mazzei, D. R. et al. Are education, exercise and diet interventions a cost-effective treatment to manage hip and knee osteoarthritis? A systematic review. Osteoarthritis Cartilage 29, 456–470 (2021).
Google Scholar
Shi, J. et al. Cost effectiveness of pharmacological management for osteoarthritis: a systematic review. Appl. Health Econ. Health Policy 20, 351–370 (2022).
Google Scholar
Szilagyi, I. A. et al. Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression. Rheumatology 62, 1286–1295 (2023).
Google Scholar
Groen, S. S. et al. Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis. Arthritis Res. Ther. 26, 107 (2024).
Google Scholar
Stecher, R. M. Heberden’s nodes: the clinical characteristic of osteo-arthritis of the fingers. Ann. Rheum. Dis. 7, 1–8 (1948).
Google Scholar
Long, H., Cao, R., Yin, H., Yu, F. & Guo, A. Associations between obesity, diabetes mellitus, and cardiovascular disease with progression states of knee osteoarthritis (KOA). Aging Clin. Exp. Res. 35, 333–340 (2023).
Google Scholar
Herrero-Beaumont, G. et al. Systemic osteoarthritis: the difficulty of categorically naming a continuous condition. Aging Clin. Exp. Res. 36, 45 (2024).
Google Scholar
link